These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 658547
1. In vitro immunization against tumour-associated antigen of methylcholanthrene-induced sarcoma. Indrová M, Bubeník J. Folia Biol (Praha); 1978; 24(2):118-27. PubMed ID: 658547 [Abstract] [Full Text] [Related]
7. Non T suppressor cells in the lymph nodes of mice bearing methylcholanthrene-induced sarcomas. Indrová M, Bubeník J. Folia Biol (Praha); 1981; 27(3):217-22. PubMed ID: 6455309 [Abstract] [Full Text] [Related]
13. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines. Kono K, Petersson M, Ciupitu AM, Wen T, Klein G, Kiessling R. Cancer Res; 1995 Dec 01; 55(23):5648-55. PubMed ID: 7585649 [Abstract] [Full Text] [Related]
17. Cytotoxicity in vitro by products of specifically stimulated spleen cells: susceptibility of tumor cells and normal cells. Meltzer MS, Bartlett GL. J Natl Cancer Inst; 1972 Nov 01; 49(5):1439-43. PubMed ID: 4568090 [No Abstract] [Full Text] [Related]
18. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages. Harmel RP, zbar B. J Natl Cancer Inst; 1975 Apr 01; 54(4):989-92. PubMed ID: 1127729 [Abstract] [Full Text] [Related]
19. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice. Vaage J. Cancer Res; 1972 Feb 01; 32(2):193-9. PubMed ID: 5058179 [No Abstract] [Full Text] [Related]
20. The role of blocking antibodies in immunological enhancement. Takasugi M, Klein E. Immunology; 1971 Oct 01; 21(4):675-84. PubMed ID: 5121758 [Abstract] [Full Text] [Related] Page: [Next] [New Search]